Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Operating Expenses (2016)

Historic Operating Expenses for Tenax Therapeutics (TENX) over the last 6 years, with Q4 2016 value amounting to $42.2 million.

  • Tenax Therapeutics' Operating Expenses changed N/A to $42.2 million in Q4 2016 from the same period last year, while for Sep 2017 it was $42.2 million, marking a year-over-year increase of 36038.11%. This contributed to the annual value of $19.5 million for FY2024, which is 13675.01% up from last year.
  • Tenax Therapeutics' Operating Expenses amounted to $42.2 million in Q4 2016.
  • Tenax Therapeutics' 5-year Operating Expenses high stood at $75.7 million for Q2 2013, and its period low was $1.2 million during Q4 2012.
  • Moreover, its 4-year median value for Operating Expenses was $4.6 million (2016), whereas its average is $21.0 million.
  • Data for Tenax Therapeutics' Operating Expenses shows a peak YoY increase of 240143.99% (in 2012) and a maximum YoY decrease of 4427.64% (in 2012) over the last 5 years.
  • Tenax Therapeutics' Operating Expenses (Quarter) stood at $1.2 million in 2012, then soared by 6222.71% to $75.7 million in 2013, then crashed by 91.83% to $6.2 million in 2015, then surged by 582.62% to $42.2 million in 2016.
  • Its Operating Expenses stands at $42.2 million for Q4 2016, versus $4.5 million for Q3 2016 and $4.7 million for Q2 2016.